UK-based startup Kheiron Medical Technologies, dedicated to AI analysis of breast cancer, has successfully developed a mammography intelligence assessment (Mia) system with high cancer screening sensitivity and specificity, according to the firm's Compliance and Clinical Ops Lead Annie Ng.
Ng said at a UK Innovation Medtech Workshop held alongside the recent BIO Asia-Taiwan 2019 that her company's Mia system can provide a suggestion of whether a women should be called back from screening or not and highlight regions of interest.
She continued that Kheiron's Mia system carries a screening sensitivity of 90% and specificity of 89%, compared to 75-87% for the former and 85-89% for the latter. Additionally, the Mia system can be integrated with the Picture Archiving and Communication System (PACS) to help doctors work out better medical care solutions for patients.
Ng also noted that Kheiron has won the ISO 13485 medical devices, quality management systems requirements certification, and is the first British company certified by CE for a radiological deep learning software.